The thesis is focused on the assessment of nurse's knowledge in the prevention of catheter sepsis. The aim of the study was to expertise knowledge in the prevention of catheter sepsis among nurses working in intensive care units. Map out the latest theoretical and practical possibilities of nurses working in intensive care units in the prevention of catheter-related sepsis of hospitalized patients. The work is divided into theoretical and practical part. The theoretical part consists of three chapters. In the first chapter, we focused on a theoretical overview of nosocomial and bloodstream infections. The second chapter is focused on an overview of invasive inputs. The third chapter focuses on prevention of catheter sepsis. Practical part was divided into two chapters. In the first section of the empirical part of the diploma thesis, which is the fourth chapter, we characterized the survey sample, the evaluation of the survey data that have been collected through the questionnaire. Practical part was divided into two chapters. The fifth chapter consists of discussion and suggestions. Key words: sepsis, prevention, nursing, catheter, nurse, hospitalization.

Introduction: Communication between neuroendocrinne and immune system is arranged by hormones and cytokines in endocrinne, paracrinne and autocrinne manner. One of the factors involved is also prolactin, a pituitary hormone and an immune cytokine. Sepsis is a system reaction to inflammation mediated by Th1 immune response, which is supported by prolactin as well. Primary protection against sepsis is mediated by innate immunity. Toll- like receptors distinguish molecules, which are connected with pathogens. Afterwards this identification of a specific pathogen toll-like receptors trigger immune reaction with the main goal of destroying this pathogen and also with the goal of renewing the balance of the organism. It is supposed that in the organism that is hardly attacked by a pathogen, the PRL, TLR2 and TLR4 gene expression is on the increase. We studied the levels of PRL, TLR2 and TLR4 mRNA production in circulating monocytes derived from septic patients. Simultaneously, the effect of PRL -1149 G/T SNP on physiological levels of PRL mRNA and its expression in the course of sepsis was evaluated. Materials and methods: As a source of monocytes, blood specimens from 43 septic patients and 40 healthy controls were used. The blood of septic patients was taken three times with some time difference and...

No description available.

Sepsis, a life-threatening condition which results from a dysregulation of host response to infection and leads to multiple organ dysfunction, is a cause for great concern. The current gold standard of detection – Blood culturing – is a highly time-consuming process and so, research has proposed the use of biomarkers. Current biomarkers, C-reactive protein and Procalcitonin, though good indicators, individually show certain limitations with respect to the specificity and sensitivity. Hence, as a step forward from singleplex biomarkers, the development of a multi-marker panel was suggested. For this purpose, the use of microRNAs (miRNAs) were employed to serve as potential biomarkers for the detection of sepsis. The aim of this study was to determine whether a higher concentration of miRNA would be obtained from a larger volume of plasma as well as to see if the miRNA present in blood can be used for the diagnosis of sepsis. Extractions were carried out using the QIAGEN exoRNeasy Plasma: Midi & Maxi Kits from plasma and Norgen’s Total RNA Purification Kit from blood. The samples were analysed and quantified using the Qubit® microRNA assay kit & Qubit® 3.0 Fluorometer and the NanoDrop™ 2000 Spectrophotometer. Statistical analysis of the results revealed that there was a significant difference between miRNA concentrations in the two volumes of plasma analysed. Based on the accurate Qubit measurements and readings, it was concluded that a larger volume of plasma, does yield a higher concentration of miRNA. In addition, it was also established that the miRNA detected in blood, could be used as probable biomarkers for the diagnosis of sepsis.

Vor dem Hintergrund der steigenden Inzidenz und der nahezu unverändert hohen Letalität der schweren Sepsis wurden in den letzten Jahren beeindruckende Fortschritte auf dem Gebiet der Diagnostik und v.a. der Therapie der Sepsis erlangt. Ziel der vorliegenden Arbeit war es, den Einfluss des neuen Medikaments Drotrecogin alpha (aktiviert) auf Patienten mit septischem Schock bzgl. Mortalität zu prüfen und Kriterien, die auf eventuellen Erfolg bzw. Misserfolg hinweisen, zu identifizieren. Hierzu wurden die Akten von 63 Patienten mit septischem Schock, die zwischen Oktober 2002 und September 2006 auf der internistischen Intensivstation der Medizinischen Klinik und Poliklinik I des Universitätsklinikums Würzburg betreut wurden, ausgewertet. Die ermittelten Daten wurden in Bezug auf neuere Literatur analysiert. Alle Patienten (44 Männer, 19 Frauen, Durchschnittsalter 53,4 ± 13,7 Jahre) wurden zusätzlich zur Standardsepsistherapie mit DrotAA (24 µg/kg KG/h) für eine Gesamtzeit von max. 96 h behandelt. Jedem Patienten mussten zur Kreislaufstabilisierung Katecholamine verabreicht werden, folglich befanden sich per definitionem alle Studienteilnehmer im septischen Schock. Der durchschnittliche Apache II-Score lag bei 36 und die mittlere Anzahl an Organversagen war 4,4 (100 % der Patienten erlitten ein Kreislaufversagen, 94 % hatten ein Lungenversagen, 78 % ein Nierenversagen, 68 % eine metabolische Azidose, 64 % eine DIC, 35 % ein Leberversagen). Insgesamt verstarben 30 der 63 Patienten (47,6 %) innerhalb von 30 d nach Beginn der Applikation von DrotAA. 46 % unserer Patienten sind innerhalb von 24 h nach Aufnahme auf die ITS mit DrotAA behandelt wurden. In der statistischen Analyse zeigte sich der Beginn der Therapie mit DrotAA innerhalb von 24 h jedoch nicht als signifikanter Prädiktor für die 30 d-Mortalität (HR: 0,87; 95 % CI: 0,422 – 1,791; p = 0,705). Die unabhängigen Prädiktoren des 30 d-Mortalitätsrisikos waren die Anzahl an Organversagen (HR je Organ: 1,51; 95 % CI: 1,14 – 1,99; p = 0,004), die Anzahl an verabreichten Antibiotika (HR je Medikament: 0,57; 95 % CI: 0,42 – 0,79; p = 0,001), das Ansteigen des Noradrenalinbedarfs (HR: 2,884; 95 % CI: 1,156 – 7,195; p = 0,023), das Ansteigen des CRP-Wertes (HR: 1,453; 95 % CI: 0,970 – 2,177; p = 0,070), sowie das Abfallen des Quick- (HR: 0,520; 95 % CI: 0,283 – 0,953; p = 0,034) bzw. des pH-Wertes (HR:0,428; 95 % CI: 0,188 – 0,973; p = 0,043). Verglichen mit der Literatur [45], war eine Behandlung mit DrotAA bei Patienten mit einem Apache II-Score ≥ 25 mit einem reduzierten Mortalitätsrisiko assoziiert. Signifikant war diese Differenz bei Patienten mit einem Apache II-Score von 35 – 44. Bei keinem der 63 Patienten traten während der Gabe von DrotAA intrakranielle Blutungen oder Blutungen, die die Gabe von mehr als drei Blutkonserven notwendig machten, auf. Mit den Daten dieser hier vorliegenden Untersuchung konnte gezeigt werden, dass eine DrotAA-Behandlung bei Patienten mit septischen Schock und höchsten Mortalitätsrisiken mit einem besseren Outcome assoziiert ist, als es entsprechend des Apache II-Scores zu erwarten wäre. / Introduction: Against the background of increasing incidence and high lethality of severe sepsis, substantial progress in diagnostic and therapy was achieved in the last years. Activated drotrecogin alpha (DrotAA) is a new medication for severe sepsis. As a recombinant form of human activated protein C it has anti-thrombotic, anti-inflammatory and profibrinolytic properties. According to large trials the use of DrotAA should be restricted to patients with severe sepsis and highest risk of death. While these studies suffered from major exclusion criteria, this case-series presents the experience with DrotAA in “real world“ patients with septic shock and multi-organ failure. Methods: Between October 2002 and September 2006 63 patients with septic shock were treated with DrotAA (24 µg/kg/hr for up to 96 hours) in addition to standard care at the intensive care unit of the University Hospital Würzburg. The patient files were analysed retrospectively with regard to mortality in order to find criteria indicating a potential success or failure of the therapy. Results: All patients (44 men, 19 women, mean age 53.4±13.7 years) were treated with DrotAA (24 µg/kg/hr) in addition to standard sepsis therapy. 100% of the patients were in septic shock determined by the requirement of vasopressor therapy. The average APACHE II score was 36 and the average number of failed organs was 4.4 (100% cardiovascular failure, 94% lung failure, 78% kidney failure, 68% metabolic acidosis, 64% DIC, 35% liver failure). 30 of 63 patients (47.6%) died within 30 days after the start of the DrotAA-therapy. 46% of the patients were treated with DrotAA within 24 hours after arrival to the ICU. However, the start of the DrotAA therapy within 24 hours was no significant predictor of 30-day mortality risk (HR: 0.87; 95% CI: 0.422-1.791; p=0.705). Independent predictors of 30-day mortality risk were the number of failing organs (HR per organ: 1.51; 95% CI: 1.14-1.99; p=0.004), the number of applied antibiotics (HR per drug: 0.57; 95% CI: 0.42-0.79; p=0.001), the increasing requirement of norepinephrine (HR: 2.884; 95% CI: 1.156-7.195; p=0.023), the increase of CRP (HR: 1.453; 95% CI: 0.970-2.177; p=0.070), the decrease of thromboplastin time (HR: 0.520; 95% CI: 0.283-0.953; p=0.034) and pH value (HR 0.428; 95% CI: 0.188-0.973; p=0.043). In patients with APACHE II score ≥ 25 treatment with DrotAA was associated with a reduced mortality risk. This difference was significant in patients with an APACHE II score of 35-44. During the treatment with DrotAA no patient suffered from intracranial hemorrhage or bleedings requiring the application of three or more erythrocyte concentrates. Conclusion: Targeting treatment with DrotAA to patients with septic shock, multi-organ failure and high risk of death is associated with better survival than anticipated from baseline APACHE II scores although mortality risk remains still very high.

Streptococcus agalactiae, ou Estreptococo do Grupo B, é um microrganismo que encontrado na microbiota intestinal, vaginal e/ou geniturinária de 10-30% de mulheres saudáveis. A principal infecção causada por S. agalactiae é a sepse neonatal. O bebê pode adquirir o microrganismo durante o parto ao passar pelo canal vaginal, ou até mesmo durante a gestação, caso haja ascensão de S. agalactiae para o útero. Existem diversos fatores associados à infecção do feto por S. agalactiae quando a mãe é colonizada, tais como fator CAMP, cápsula de polissacarídeos, hialuronidase, β-citolisina/hemolisina e pili. Não existe consenso ou recomendação técnica sobre o tema no Brasil. Segundo o Caderno de Atenção Básica ao Pré-Natal, não existem estudos que levem à recomendação da antibioticoterapia intraparto. É necessário elucidar as características genotípicas de cepas de S. agalactiae isoladas no Brasil para alinhar as práticas clínicas às características fenotípicas do microrganismo. Desta forma, os objetivos deste projeto são: i) classificar cepas de S. agalactiae isoladas de gestantes e não gestantes quanto ao sorotipo capsular, por PCR Multiplex, ii) avaliar a presença e distribuição de fatores de virulência, por PCR e iii) avaliar o perfil de resistência antimicrobiana, pelo método de disco difusão e teste D. Os achados de virulência e resistência a antimicrobianos foram comparados com os sorotipos, gestação, localização geográfica e sítio de isolamento. Foram analisadas 292 cepas isoladas de gestantes e não gestantes em São Paulo, São José dos Campos e Rio de Janeiro. O sorotipo Ia foi o mais prevalente entre as cepas. Na cidade de São José dos Campos não houve diferença significativa entre a prevalência dos sorotipos Ia e V, sendo que o sorotipo V foi mais abundante do que nas cidades de São Paulo e Rio de Janeiro. O sorotipo II foi mais abundante em mulheres não gestantes do que gestantes. Não foram encontradas cepas resistentes à Penicilina e vancomicina; contudo a resistência a Cefepima, Eritromicina e Clindamicina ficou em torno de 22%. Foram encontradas diferenças entre os sorotipos quanto à resistência, genes de virulência e sítio de isolamento das cepas. Portanto essas diferenças podem se refletir no perfil epidemiológico da infecção por S. agalactiae quanto à localização geográfica também quanto à gestação. A incidência de sepse causada por S. agalactiae diminuiu muito nas últimas décadas, contudo o monitoramento constante é necessário para alinhar as práticas clínicas às características fenotípicas do microrganismo. / Streptococcus agalactiae, or Group B Streptococcus, is a microorganism found in intestinal, vaginal and/or genitourinary microbiota from about 10-30% of all healthy women. The main infection caused by S. agalactiae is neonatal sepsis. The baby can contract the infection during labor when passing through the vaginal canal, or even during pregnancy, if S. agalactiae ascends from the vaginal canal to the uterus. There are several factors associated to the infection of the fetus by S. agalactiae when the mother is colonized, such as the CAMP factor, polysaccharide capsule, hyaluronidase, β-cytolysin/hemolysin and pili. There is no consensus or technical recommendation regarding this theme in Brazil. According to the Brazilian guidelines to prenatal care, there is no research that justifies the implementation of intrapartum antibiotic therapy. There is a need to clarify genotype characteristics of S. agalactiae strains isolated in Brazil in order to align clinical practices to phenotypical characteristics of this microorganism. This way, the goals of this project are: i) to classify S. agalactiae strains isolated from pregnant and nonpregnant women according to their capsular serotype, using PCR Multiplex, ii) to evaluate the presence and distribution of virulence factors, using PCR and iii) to evaluate their antibiotic resistance profile, using disk-diffusion and D-zone tests. The findings regarding virulence and resistance were compared to serotypes, pregnancy, geographic localization and the site where the sample was isolated. A total of 292 strains from pregnant and nonpregnant women from the cities of São Paulo, São José dos Campos and Rio de Janeiro were analyzed. Serotype Ia was the most prevalent among the strains. In São José dos Campos there was no significate difference in the prevalence of serotypes Ia and V. Serotype V was the most abundant in São Paulo and Rio de Janeiro. Serotype II was most prevalent in nonpregnant women when compared to pregnant women. No resistance to Penicillin nor Vancomycin was found. However, resistance to Cefepime, Erythromycin or Clindamycin was found in around 22% of strains. There were differences among serotypes regarding resistance, virulence genes and site where the strain was isolated. Therefore these differences can reflect into the epidemiologic profile of S. agalactiae infection in regards to geographic localization and pregnancy. The incidence of sepsis caused by S. agalactiae has decrease in the last few decades, however constant monitoring is necessary in order to align clinical practice to the microorganisms phenotypical characteristics.

Bakgrund: Globalt drabbas 30 miljoner människor varje år av sepsis varav ca 5 miljoner människor dör. Forskning har fokuserat på överlevnad och den kunskapen har gjort att fler överlever. En tredjedel av de personer som överlevt sepsis drabbas av restsymtom och en sjättedel får kvarstående men för livet. Livskvalitet är en subjektiv upplevelse av välbefinnande och är beroende av flera faktorer. Hälso- och sjukvården ska bedriva personcentrerad omvårdnad och se patienten i sin helhet. Syfte: Syftet var att beskriva livskvalitet hos patienter som överlevt sepsis. Metod: Studien har genomförts som en litteraturöversikt och rymmer 18 artiklar. Datainsamling har skett i databaserna Cinahl Complete, PubMed samt PsycINFO. Resultat: Totalt 17 kvantitativa artiklar och en kvalitativ artikel inkluderades i litteraturöversikten. Resultatet visar att personer som överlevt sepsis blir påverkade inom fyra domäner; fysisk-, kognitiv-, psykisk- och social livskvalitet. Diskussion: Personer som överlever sepsis har ökad risk för fysisk, kognitiv, psykisk och social påverkan på livskvaliteten och söker i stor utsträckning vård. Det är viktigt att sjuksköterskan har kunskap kring de restsymtom som personerna kan drabbas av, en förståelse för det den gått igenom och en uppfattning om hur detta kan påverka deras livskvalitet.

O controle de respostas imunes patológicas (autoimunidade, alergia, rejeição de transplantes) tem sido um dos principais objetivos dos imunologistas. Apesar dos avanços recentes, a maioria dos tratamentos atuais ainda procura diminuir a imunidade e inflamação em vez de restabelecer o estado saudável da tolerância imunológica. Sepse é uma doença desencadeada pela presença de bactérias e/ou produtos bacterianos como lipopolissacarídeos (LPS), componente principal da membrana externa de bactérias gram-negativas, ativando a resposta imune do hospedeiro. A caracterização do perfil de linfócitos na resposta à tolerância ao LPS são de extrema importância para a contribuição do estudo da imunodepressão na sepse. O objetivo deste estudo foi investigar se a comprovada redução de mortalidade previamente vista em modelo de sepse animal através tolerância ao LPS, pode ser associada com o aumento da população de linfócitos T CD4+ regulatórios e Th17. Camundongos machos C57/6, receberam por via subcutânea ( s.c.) injecções de LPS ( 1mg/kg ) durante 5 dias , seguido por perfuração e ligadura cecal (CLP ) . Citocinas e linfócitos marcados foram medidos durante, após a tolerância e o desafio CLP. Ambos os subtipos de células T analisados Treg e Th17 , mostrou aumento destas células no baço durante e após a tolerância. Este estudo demonstrou que a mortalidade reduzida depois de tolerância previamente constatada pode ser associada com o aumento da população de células T regulatórias e Th17 devido a imunorregulação do hiperinflamação e recrutamento de neutrófilos / The control of pathological immune responses (autoimmunity, allergy, transplant rejection) has been a major goal of immunologists. Despite recent advances, most current treatments still seeks to reduce immunity and inflammation rather than restore the healthy state of immune tolerance. Sepsis is a disease triggered by the presence of bacteria and / or bacterial products like lipopolysaccharide (LPS), the main component of the outer membrane of gram-negative bacteria, activating the immune response of the host. The characterization of lymphocyte profile in response to LPS tolerance is extremely important for the study of immunosuppression in sepsis contribution. The aim of this study was to investigate whether the proven reduction in mortality seen previously in animal sepsis model by tolerance to LPS, can be associated with the increase in population of CD4 + regulatory and Th17. Mice C57 / 6 mice received subcutaneous (s.c.) injection of LPS (1mg / kg) for 5 days, followed by cecal ligation and puncture (CLP). Cytokines and marked lymphocytes were measured during after tolerance and CLP challenge. Both subtypes of T cells Treg and Th17 analyzed showed an increase of these cells in the spleen during and after tolerance. This study demonstrated that reduced mortality after previously seen tolerance may be associated with increasing the population of regulatory T cells and Th17 because immunoregulation of the hiperinflamação and neutrophil recruitment

No paciente séptico, utiliza-se como tratamento inicial a reposição volêmica com o objetivo de restabelecer a pressão arterial e consequentemente a perfusão tecidual. Os pacientes não responsivos a expansão volêmica usualmente são tratados com medicações vasoativas. O emprego desses fármacos tais como noradrenalina, nessa situação, torna-se imprescindível, porém a hiporresponsividade do sistema adrenérgico é um obstáculo rotineiro em pacientes sépticos. A vasopressina aparece como uma alternativa, tanto como fármaco de primeira escolha como resgate quando o tratamento com vasoativos adrenérgicos falha. A avaliação da microcirculação é imprescindível visto a sua importância na patogênese da sepse, e no acompanhamento das diferentes terapias. Assim sendo, o presente projeto tem por objetivo avaliar o uso da vasopressina e da noradrenalina no tratamento da hipotensão de cães em sepse decorrente de piometra por meio imagem espectral obtida através da polarização ortogonal (OPS) e sobre variáveis hemodinâmicas, bem como sobre parâmetros de oxigenação e ventilação. Foram utilizados 13 cães em sepse grave apresentando no mínimo duas variáveis da resposta inflamatória sistêmica e no mínimo uma variável de disfunção orgânica na avaliação inicial. Em todos os animais foi realizada ressuscitação volêmica inicial com 15ml/kg em 15 minutos de solução de Ringer com lactato. Caso durante a anestesia a pressão arterial média não assumir valores superiores a 65 mmHg e a pressão venosa central não variasse 2mmHg ou apresentasse valores superiores a 8 mmHg, os animais foram distribuídos em dois grupos. O Grupo VASO recebeu inicialmente 0,0002UI/kg/min de vasopressina e o Grupo NORA 0,05 mcg/kg/min noradrenalina, podendo ter o incremento de 0,0002U/kg/min e 0,02 mcg/kg/min da dose inicial, respectivamente, com o objetivo até se atingir a PAM acima de 65mmHg. Foram confrontados os parâmetros de valores de densidade e fluxo encontrados com o OPS nos dois grupos, bem como dados hemodinâmicos e de ventilação. As imagens coletadas utilizando o OPS foram processadas e analisadas por software especifico. Nao houve diferenca estatistica entre os grupos estudados nos parametros, hemodinamicos, ventilatorios, de oxigenacao e da microcirculacao encontrados com o OPS. A frequência cardíaca foi menor no grupo VASO no momento TG quando comparada ao grupo NORA. Os parametros de densidade e fluxo capilar não diferiram do basal em nenhum dos grupos. Deste modo, conclui-se que tanto a vasopressina quanto a noradrenalina quando empregadas para o tratamento de hipotensao decorrente da sepse grave/choque septico, nao prejudicam a microcirculacao / In septic patients, volume replacement is used as initial treatment in order to restore blood pressure and consequently the tissue perfusion. Nonresponders patients to the increase in preload are usually treated with vasoactive medications. Those agents such as norepinephrine, in this situation, it is essential, but the hyporesponsiveness of the adrenergic system is a common obstacle in septic patients. Vasopressin is an alternative, both like the drug of choice as rescue when treatment of adrenergic hyporesponsiveness. The evaluation of microcirculation is essential for its importance in the pathogenesis of sepsis, and to guide the different therapies. The aim of this project is to evaluate the use of vasopressin and norepinephrine in the treatment of hypotension in sepsis in dogs due to pyometra through spectral image obtained by orthogonal polarization (OPS) and on hemodynamic variables, as well as oxygenation and ventilation parameters. Thirteen dogs in severe sepsis were used, presenting at least two variables of systemic inflammatory response and at least one organ dysfunction variable at baseline. In all animals was performed initial volume resuscitation with 15ml / kg in 15 minutes of Ringer\'s lactate solution. If during anesthesia mean arterial pressure not assume values greater than 65 mmHg and central venous pressure did not vary 2 mmHg or present values greater than 8 mmHg, the animals were divided into two groups. The Group VASO received 0,0002UI / kg / min of vasopressin and Group NORA 0.1 mcg / kg / min of noradrenaline, may have increment 0,0002U / kg / min and 0. 1mcg / kg / min initial dose, respectively, in order to achieve MAP above of 65 mmHg. The density values of parameters were compared and found flow with OPS in both groups, and hemodynamic data and ventilation. The images collected using OPS were processed and analyzed by specific software. There was no statistical difference between the groups studied in the parameters, hemodynamic, ventilation, oxygenation and microcirculation found with OPS. The heart rate was lower in group VASO in TG moment compared to NORA group. The density and capillary flow parameters from baseline were similar in all groups. Thus, it is concluded that both noradrenaline and vasopressin when used to treat hypertension caused by severe / sepsis, septic shock, do not impair the microcirculation

A mortalidade decorrente de processos infecciosos em pacientes oncológicos, livres ou não de doença, ainda é alta. Teve-se como objetivo além da avaliação da mortalidade e das características clínicas e laboratoriais dos pacientes pediátricos oncológicos infectados, admitidos na Unidade de Terapia Intensiva Pediátrica (UTIP) do Hospital A.C. Camargo no período de 1º de janeiro de 2004 a 31 de dezembro de 2008, avaliar a associação dessas características à mortalidade. Estudou-se 148 internações de 97 pacientes, sendo que 31 indivíduos foram internados mais de uma vez (1-6 internações por indivíduo). 52,6% da população era do sexo feminino, a idade média foi de aproximadamente 8 anos, 67% dos pacientes encontravam-se eutróficos na primeira internação e 50,5% das neoplasias eram leucemias (34/97) e linfomas (15/97). Dos pacientes com neoplasias hematológicas, 40,8% internaram mais de uma vez, enquanto 29,9% daqueles portadores de tumores sólidos tiveram internações repetidas. Foi utilizado teste qui-quadrado de Pearson para analisar a associação entre duas variáveis categóricas, teste t de Student para as variáveis contínuas e teste t de Student pareado para as associações dependentes. Empregou-se a regressão logística para calcular a Razão de Chances (Odds Ratio - OR) para as medidas de associação. Dos 97 pacientes, 17 morreram durante a internação na UTIP, ou seja, 11,5% das 148 internações evoluiram para óbito. Observou-se uma mortalidade maior no grupo de pacientes que tiveram mais de uma internação 32,3% (p=0,012), com chance de óbito de 4 em relação a quem internou apenas 1 vez (OR=4,01[IC95%:1,35 -11,90]). Também foi encontrada associação significativa entre estado hemodinâmico (choque séptico, sepse grave e sepse) à admissão na UTIP com evolução para alta e óbito (p=0,001). Quando o paciente apresentava choque na admissão o risco de óbito foi de 11 vezes em relação a quando não apresentava (OR=11,4[IC95%:2,5-51,9]). A variação na dosagem da proteína C reativa 24 horas pré-admissão e à admissão na UTI, também demonstrou associação estatisticamente significativa com a evolução para óbito (p= 0,029). Não houve associação entre sexo, doença de base, estado nutricional, intervalo de quimioterapia, contagem de neutrófilos, sítio de infecção, variação de frequência cardíaca, frequência respiratória, pressão arterial média e óbito. Esse trabalho demonstrou que existe uma associação entre estado hemodinâmico à admissão na UTIP e óbito, o que incita a realização de novos estudos para descoberta de fatores que possam prever a evolução de um quadro infeccioso para choque séptico e selecionar os pacientes que devam ser transferidos mais precocemente para UTIP a fim de aumentar a chance de sobrevida. / The mortality due to infectious processes in oncologic patients, with or not active disease, is still high. The objective of this study is evaluation of mortality and clinical and laboratory characteristics of pediatric oncology infected admitted to the Hospital AC Camargo\'s Pediatric Intensive Care Unit in the period from January 1st, 2004 to December 31st, 2008, and association of these characteristics with mortality. One hundred and forty eight admissions in 97 patients were analyzed. Thirty one patients were hospitalized more than once (2-6 admissions per individual). 52.6% of the population was female, the average age was approximately 8 years, 67% of patients were eutrophic during the first hospitalization and 50.5% were leukemias (34/97) and lymphomas (15/97). Among patients with hematologic disease, 40.8% were hospitalized more than once, while 29.9% of those patients with solid tumors had repeated hospitalizations for infection during the study period. It was used the Pearson chi-square test to analyze the association between two categorical variables, Student t test for continuous variables, a variant of Student t test to measure the variation between two paired measurements from the same individual. Logistic regression was used to calculate Odds Ratio (OR) for measures of association. Among 97 patients, 17 died during hospitalization in PICU, ie 11.5% (17/148) of the admissions lead to death. A higher mortality in patients who had more than one hospitalization 32.3% (p = .012), with OR = 4.01 [95% CI: 1.35 -11.90] was observed. It was also found a significant association between hemodynamic status (septic shock, severe sepsis and septic) for admission to the PICU with evolution to discharge and death (p = 0.001). Septic shock and death were observed with a OR 11.4 [95%CI: 2 0.5 to 51, 9]. The variation of C-reactive protein dosage 24 hours pre-admission and admission to the ICU, also showed a significant association with progression to death (p = 0.029). There was no significant association between sex, underlying disease, nutritional status, interval of chemotherapy, neutrophil count, site of infection, changes in heart rate, respiratory rate variation, variation in medium blood pressure and death. This data demonstrates that there is an association between hemodynamic status on admission to the PICU and death, which encourages new studies to discover factors that might predict the course of an infection to septic shock and select patients who should be transferred earlier PICU in order to increase the chance of survival.